Press

VALUATIONS AND EXIT STRATEGIES FOR MEDTECH COMPANIES IN THE NEW ECONOMY ANALYZED IN ONLINE INDUSTRY PRESENTATION BY MEDICAL CAPITAL ADVISORS CHAIRMAN & CEO CHRISTOPHER J.P. VELIS

HUNTINGTON BEACH, Calif.-January 27, 2010--(BUSINESS WIRE)-- Life Science Intelligence (LSI) announced today that medical technology investment banking veteran Christopher J.P. Velis of Medical Capital Advisors would kick off their Emerging Medical Technologies Spotlight – an online event showcasing 40 emerging medical device companies – with an industry presentation titled “Valuations and Exit Strategies for Medtech Companies in the New Economy: The 10 Things Every Startup, Investor, and Dealmaker Needs to Know.” Mr. Velis’ one-hour industry presentation, which will be released in an interactive webinar format, will provide startup CEOs, business development executives, and venture capitalists with a practical and realistic picture of what to expect in terms of valuations and exits in 2010. Mr. Velis’ discussion will be followed by detailed business presentations from the CEOs of 40 privately-held emerging medical device companies selected by event host Life Science Intelligence. Each of the 40 presenting companies is seeking strategic partners and/or raising capital. Register here to access the event.

Attendees receive online access to Mr. Velis’ presentation and 10-15 minute CEO presentations (audio and slides); a notebook of executive summaries; and detailed information, such as: development stage, competitive landscape and positioning, technological advantage, target markets, sales forecasts, financial and fund raising status, management team, IP position, exit strategy, and contact details.

Companies on the program thus far include: Aardvark Medical, Advanced Ophthalmic Pharma, Angel Medical Systems, ArtVentive Medical, Bakhtar Medical Imaging, Biomedix, Branching Tree, CardioMag, Cardious, Epinex Diagnostics, Heart Test Labs, Izun Pharmaceuticals, Lerner Medical Devices, LightIntegra, MEDTRONS, Mobius Therapeutics, Near Infrared Imaging, NuOrtho Surgical, Optical Imaging, Pico-Tesla Magnetic Therapies, PolyRemedy, Qscope, Renova Orthopedics, Sara Medical Devices, Seguro Surgical, Smart Association, SMT R&D, Solstice Medical, SonoCiné, Sound Interventions, Sound Surgical Technologies, Spinetronics, TonoGuard, Vertech, VisiTube, and Vytrace.

LSI’s Emerging Medical Technologies Spotlight is a travel-free online event, which serves as a convenient forum for medical technology innovators, investors, and dealmakers to connect and collaborate from their desktops. Registered attendees and select LSI members – which include the top medtech dealmaking companies and venture capital firms – will have an opportunity to quickly and efficiently preview companies and then selectively network using LSI’s proprietary and confidential online platform.

To register for this online event or for additional details, visit www.EMTspotlight.com.

About Medical Capital Advisors, LLC
Medical Capital Advisors, LLC is among Wall Street's leading, specialized investment banking advisors to the Medical Technology industry. The firm has successfully represented the financial interests of sophisticated institutional investors and Fortune 500 companies. Medical Capital Advisors' current client base includes leading medical technology firms in the largest sectors of medicine, including: orthopedic, cardiovascular, and biologic sciences. Medical Capital Advisors provides strategic advice concerning mergers and acquisitions, strategic partnerships, and capital investments to its clients.

About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors. LSI produces the Emerging Medical Technologies® database, Emerging Medical Technologies® online meetings, medtech market reports, and provides global custom market research services. www.LSintelligence.com

Contact:
Life Science Intelligence
Scott Pantel, 1-714-847-3540
scott@LSintelligence.com